Herbal medicine is still the mainstay of about 75-80% will pay rich dividends. Strategically, India should enter of the world population, mainly in the developing coun-through those plant-based medicines which are already tries, for primary health care because of better cultural well accepted in Europe, USA and Japan. Simultaneously, acceptability, better compatibility with the human body it should identify those herbs (medicinal plants) which are and lesser side effects. However, the last few years have time-tested and dispensed all over in India. seen a major increase in their use in the developed world. The basic requirements for gaining entry into deve In Germany and France, many herbs and herbal extracts loped countries include:(i) well-documented traditional are used as prescription drugs and their sales in the use,(ii) single-plant medicines,(iii) medicinal plants free countries of European Union were around $6 billion in from pesticides, heavy metals, etc.,(iv) standardization 1991 and may be over $20 billion now. In USA, herbal based on chemical and activity profile, and (v) safety and drugs are currently sold in health food stores with a stability. However, mode of action studies in animals and turnover of about $4 billion in 1996 which is anticipated efficacy in human will also be supportive. Such to double by the turn of the century1. In India, the herbal scientifically generated data will project herbal medicine drug market is about $ one billion and the export of plant-in a proper perspective and help in sustained global based crude drugs is around $80 million. Herbal market. medicines also find market as nutraceuticals(health foods) whose current market is estimated at about $80